ScribePro Limited
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
ScribePro Limited - overview
Established
2018
Location
Glasgow, Scotland, UK
Primary Industry
Software
About
Based in the UK, ScribePro Limited operates as a provider of medical recording software tailored for sports organizations, enabling efficient management of athlete care. ScribePro Limited, founded in 2018 in Glasgow, UK, specializes in developing software solutions for medical record management in sports. The company has engaged in two deals, with the most recent funding round taking place on July 8, 2025. The firm was founded by individuals with expertise in sports medicine and technology, although specific details about the founder's history are not provided.
ScribePro Team offers a comprehensive suite of medical recording software designed to enhance care across various sports and leagues. At the core of its offerings is a feature-rich web portal that facilitates the management and analysis of medical records, coupled with an intuitive mobile application that allows clinicians to input and review care while on the move. This dual-access approach aims to streamline data entry and collaboration among medical teams, enabling seamless recording and review of treatments and consultations. ScribePro Team primarily serves semi-professional and amateur sports organizations, ensuring that quality athlete care is accessible beyond elite levels.
The software is utilized across various geographical markets, catering especially to clients in the United Kingdom and other regions where sports medicine is crucial for team management. ScribePro Team generates revenue through subscription-based models, allowing clients to access its medical recording software for their teams. The firm engages directly with sports organizations, offering tailored pricing plans that accommodate the specific needs of semi-professional and amateur squads. By halving pricing for these segments, ScribePro Team makes its services more attainable, thus encouraging wider adoption of its technology.
Transactions typically involve contracts where organizations pay for access to both the web portal and the mobile application. Specific financial details regarding pricing structures for these services remain proprietary; however, the emphasis is on providing affordable, scalable solutions that enhance the quality of medical care in sports settings. In July 2025, ScribePro Limited raised an undisclosed amount of venture funding from an individual investor. The company plans to utilize this funding to increase market share, expand platform features, and develop injury tracking tools for sports medical data management.
Future product launches and enhancements are anticipated as part of this growth strategy, with specific details on new offerings still to be announced. The company aims to expand its presence in additional geographic markets, although targeted regions for this expansion have yet to be specified.
Primary Industry
Software
Sub Industries
Monitoring Equipment, Analytics & Performance Software
Website
www.scribepro.co/
Verticals
HealthTech, Mobile Apps
Company Stage
Early Stage
Total Amount Raised
Subscriber access only
ScribePro Limited - financials
| Fiscal Year Ended | Apr 30, 2022 |
|---|---|
| Revenue (USD) | - |
| % Revenue Growth (YoY) | - |
| EBITDA (USD) | - |
| Operating Income (USD) | - |
| Operating Margin | - |
| % EBITDA Margin | - |
| NET Income (USD) | - |
| % Net Margin | - |

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.